(Q41708806)

reason for deprecated rank

7 October 2017

Therapy of progressive supranuclear paralysis. Effect of methysergide and bromocriptine on various psychoneurologic and motor functions (English)

marking inconsistent with the registered/official identifier/name

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A461893

3 July 2022

author name string

S. Giménez-Roldán

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A461893

3 July 2022

C. de Andrés

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A461893

3 July 2022

E. Salinero

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A461893

3 July 2022

language of work or name

Spanish

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=461893

3 July 2022

publication date

1 April 1979

1 reference

7 October 2017

15 April 1979

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=461893

3 July 2022

published in

Revista Clínica Española

1 reference

7 October 2017

153

1 reference

7 October 2017

1

1 reference

7 October 2017

21-27

1 reference

7 October 2017

Identifiers

1 reference